<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1267545</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2023.1267545</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>CCL7 and olfactory transduction pathway activation play an important role in the formation of CaOx and CaP kidney stones</article-title>
<alt-title alt-title-type="left-running-head">Zhang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2023.1267545">10.3389/fgene.2023.1267545</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Qiankun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2290400/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wei</surname>
<given-names>Hhuiling</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2391078/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Gang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jin</surname>
<given-names>Lie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Division of Nephrology</institution>, <institution>The Fifth Affiliated Hospital of Wenzhou Medical University</institution>, <institution>Lishui Central Hospital</institution>, <institution>Lishui Hospital of Zhejiang University</institution>, <addr-line>Lishui</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Division of Traditional Chinese Medicine</institution>, <institution>The Fifth Affiliated Hospital of Wenzhou Medical University</institution>, <institution>Lishui Central Hospital</institution>, <institution>Lishui Hospital of Zhejiang University</institution>, <addr-line>Lishui</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1360322/overview">Sadeq Vallian</ext-link>, University of Isfahan, Iran</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2402028/overview">Parastoo Modarres</ext-link>, University of Isfahan, Iran</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1573406/overview">Yucheng Ma</ext-link>, Sichuan University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Gang Huang, <email>hyg91264@qq.com</email>; Lie Jin, <email>lsjingl@yeah.net</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1267545</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>11</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Zhang, Wei, Huang and Jin.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Zhang, Wei, Huang and Jin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Background:</bold> The deposition of calcium oxalate (CaOx) and calcium phosphate (CaP) is the most common cause of kidney stone disease (KSD). Whether KSDs caused by CaOx and CaP have common genetic targets or signaling pathways remained unclear.</p>
<p>
<bold>Methods:</bold> The present study utilized public data GSE73680 to analyze differentially expressed genes between CaOx or CaP tissues and normal tissues, respectively. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of co-DEGs were performed. The protein-protein interaction (PPI) network was constructed to identify hub genes, and the top hub gene was selected for gene set enrichment analysis (GSEA). Finally, real-time PCR of patients&#x2019; urine was performed to validate the bioinformatic results.</p>
<p>
<bold>Results:</bold> In total, 155 significantly co-upregulated DEGs and 64 co-downregulated DEGs were obtained from the datasets. The Gene Ontology analysis showed that DEGs were significantly enriched in chemical stimulus in sensory perception, detection of chemical stimulus in sensory perception of smell, and olfactory receptor activity. The KEGG analysis showed that the olfactory transduction pathway was significantly enriched. According to protein-protein interaction, 10 genes were identified as the hub genes, and CCL7 was the top hub gene. The olfactory transduction, maturity-onset diabetes of the young, linoleic acid metabolism, and fat digestion and absorption were significantly enriched in the high-CCL7 subgroup by GSEA. In total, 9 patients who had primarily CaOx mixed with some CaP stones and 9 healthy subjects were enrolled. The RT-PCR results showed that CCL7 level in the stone group was significantly higher than that in the control group (<italic>p</italic> &#x3c; 0.05). For the olfactory transduction pathway, the expression of OR10A5, OR9A2, and OR1L3 was significantly upregulated in the stone group compared with the control group (<italic>p</italic> &#x3c; 0.05).</p>
<p>
<bold>Conclusion:</bold> CCL7 may play a key role in the development of both CaOx and CaP, and this process may depend on olfactory transduction pathway activation.</p>
</abstract>
<kwd-group>
<kwd>kidney stone disease (KSD)</kwd>
<kwd>CCL7</kwd>
<kwd>olfactory transduction pathway</kwd>
<kwd>hub gene</kwd>
<kwd>OR10A5</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Human and Medical Genomics</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Kidney stone disease (KSD) is a common disease leading to urinary tract obstruction and even renal failure, causing a substantial economic burden (<xref ref-type="bibr" rid="B9">Jeong et al., 2011</xref>). The prevalence of KSD is nearly 9% in the adult population and continues to increase worldwide (<xref ref-type="bibr" rid="B23">Sorokin et al., 2017</xref>; <xref ref-type="bibr" rid="B21">Scales et al., 2012</xref>). Calcium stones, particularly calcium oxalate (CaOx) or calcium phosphate (CaP) alone or in combination, are responsible for 85%&#x2013;90% of all kidney stones (<xref ref-type="bibr" rid="B10">Khan et al., 2016</xref>; <xref ref-type="bibr" rid="B11">Leaf, 2010</xref>). They have common pathogenic factors, including supersaturation of calcium salts, low urine volume, and hypocitraturia (<xref ref-type="bibr" rid="B26">Worcester and Coe, 2010</xref>; <xref ref-type="bibr" rid="B2">Arcidiacono et al., 2014</xref>). However, there are some differences in physicochemical factors, metabolic factors, and histopathological factors underlying the formation of CaOx and CaP crystals (<xref ref-type="bibr" rid="B5">Daudon et al., 2016</xref>; <xref ref-type="bibr" rid="B6">Dessombz et al., 2015</xref>).</p>
<p>CaOx stones seem to develop on the kidney papillary surface attached to a CaP sub-epithelial plaque, known as Randal&#x2019;s plaques (RP) (<xref ref-type="bibr" rid="B7">Evan et al., 2003</xref>). In contrast, patients with CaP stones often have early intratubular CaP deposits in their inner medullary collecting ducts, which have distinct microscopic features compared with RP (<xref ref-type="bibr" rid="B8">Evan et al., 2014</xref>). Moreover, CaOx or CaP as the main component may correspond to very different clinical implications (<xref ref-type="bibr" rid="B16">Parks et al., 2004</xref>). Thus seeking similar or different targets and signaling pathways provides a deeper insight into the molecular mechanisms of KSD.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>2 Methods</title>
<sec id="s2-1">
<title>2.1 Microarray data</title>
<p>Gene expression profiles of GSE73680 were downloaded from the Gene Expression Omnibus (GEO) database, and expression profiling arrays were generated using GPL17077. Biopsies were taken from human renal papillary tip tissues during endoscopic kidney stone surgery. In total, 24 samples were extracted in our study, including 13 CaOx plaque tissues, 5 CaP plaque tissues, and 6 normal control tissues. Then, the following steps were sequentially applied: removing the control probe, removing the probes that matched no gene symbol, removing the gene symbol with LOC or MT, and averaging duplicated gene probes. Finally, 28,892 genes were used for further analysis.</p>
</sec>
<sec id="s2-2">
<title>2.2 Identification of differentially expressed genes (DEGs)</title>
<p>To characterize DEGs, the limma package in the R software (version 4.2.2) was used to identify DEGs between the CaOx group and the control group with the threshold of <italic>p</italic>-value &#x3c; 0.05 and &#x7c;log2 fold change (FC)&#x7c; &#x3e;1. The limma package was also used to identify DEGs between the CaP group and the control group with the threshold of <italic>p</italic>-value &#x3c; 0.05 and &#x7c; FC&#x7c; &#x3e;1. The Venn diagram was constructed using the Venn diagram package. The volcano plot of DEGs was drawn by the ggplot2 package, and the heatmap of DEGs was generated using the pheatmap package in the R software.</p>
</sec>
<sec id="s2-3">
<title>2.3 Gene ontology and KEGG pathway analysis</title>
<p>To identify the potential functions and pathways between these DEGs, Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted using David, and results were visualized using R ggplot2 package. The GO terms of biological processes (BP), molecular functions (MF), and cellular components (CC) were respectively evaluated. The top ten terms were visualized if there were more than ten terms.</p>
</sec>
<sec id="s2-4">
<title>2.4 Construction of protein-protein interaction (PPI) network and identification of hub genes</title>
<p>To systematically analyze the biological functions of the obtained DEGs, the DEGs identified previously were mapped into the online search tool STRING database, which predicted the protein functional associations and PPI. Then, the Cytoscape software (version 3.7.2) was used for constructing and visualizing the transcriptional regulatory network of common DEGs. To identify hub genes, the sides of each node were estimated and the genes were sorted based on the rank of the connection number of each gene.</p>
</sec>
<sec id="s2-5">
<title>2.5 Gene set enrichment analysis (GSEA)</title>
<p>In our study, CCL7 was finally identified as the top hub gene for GSEA. Thirteen CaOx plaque tissues and 5 CaP plaque tissues were divided into high- and low-expression groups by the median expression value of CCL7. Then, GSEA analysis was applied to compare the differences in enhanced functions or pathways between high- and low-CCL7 expression groups using clusterprofiler package in the R software. Adjusted <italic>p</italic>-value &#x3c; 0.05 was considered statistically significant.</p>
</sec>
<sec id="s2-6">
<title>2.6 Patients for experimental verification</title>
<p>In total, 9 patients with primarily CaOx mixed with CaP stones and 9 healthy subjects with similar gender and age were enrolled from April to October 2023. Patients&#x2019; kidney stone samples were collected after percutaneous nephrolithotomy, and stone composition was confirmed by the infrared spectrum analysis method. Patients with any evidence of kidney infection or dysfunction, a history of urinary tumors, or those younger than 18 years were excluded. On admission, midstream morning urine was collected from all participants before giving any medicine. This study was approved by the Human Ethics Committee of the Lishui Central Hospital (approved number 2023054). All patients signed the informed consent before participation.</p>
</sec>
<sec id="s2-7">
<title>2.7 Urine RNA isolation</title>
<p>Fresh urine was centrifuged 5000&#xa0;rpm for 5&#xa0;min, then discarded the supernatant. Total RNA was extracted from urine using RNAUrineKit (Solarbio, R1300-100T, China) according to the manufacturer&#x2019;s instruction. The quality of all RNA samples was checked before downstream molecular biology applications. We used a tool for RNA quality assessment, called the RNA Integrity Number (RIN) which developed by Agilent Technologies. The RIN ranging from1 (degraded) to 10 (intact) was established by Agilent Bioanalyzer 2,100(Agilent Technologies). A RIN higher than five was used for downstream application. The concentration was assessed by NanoDrop 2000 (Thermo Fisher, United States). Extracted RNA samples with more than 50&#xa0;ng/&#x3bc;L concentrations were used for analysis.</p>
</sec>
<sec id="s2-8">
<title>2.8 Real-time PCR analysis</title>
<p>The reverse transcription kit (Takara, RR037A, Japan) was applied to synthesize cDNA (CCL7, OR10A5, OR9A2, and OR1L3) according to the manufacturer&#x2019;s protocol. RT-PCR was accomplished using HotStart&#x2122; 2X SYBR Green qPCR Master Mix (APExBIO, K1070, USA) to amplify these genes with primer pairs (<xref ref-type="table" rid="T1">Table 1</xref>). Total RNA of 1&#xa0;&#x3bc;g was used for cDNA synthesis. All primers were synthesized by Sangon Biotech. formula 2<sup>-&#x25b3;&#x25b3;Ct</sup> was used to analyze the relative changes in mRNA expression from RT-PCR (<xref ref-type="bibr" rid="B17">Pfaffl, 2001</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>List of primer pairs used in RT-PCR.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Primer names</th>
<th align="left">Sequence (5&#x2019;&#x2192;3&#x2032;)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">CCL7-F</td>
<td align="left">AGT&#x200b;GTC&#x200b;ACC&#x200b;GAC&#x200b;ATT&#x200b;TAC&#x200b;CTC&#x200b;C</td>
</tr>
<tr>
<td align="left">CCL7-R</td>
<td align="left">AAG&#x200b;GCG&#x200b;GTA&#x200b;GTG&#x200b;AAT&#x200b;TTG&#x200b;CAC</td>
</tr>
<tr>
<td align="left">OR10A5-F</td>
<td align="left">CAT&#x200b;TCT&#x200b;TCA&#x200b;CCT&#x200b;CGC&#x200b;TAT&#x200b;TTC&#x200b;TC</td>
</tr>
<tr>
<td align="left">OR10A5-R</td>
<td align="left">ATC&#x200b;TTG&#x200b;TGT&#x200b;TCC&#x200b;TAT&#x200b;ACT&#x200b;CGC&#x200b;A</td>
</tr>
<tr>
<td align="left">OR1L3-F</td>
<td align="left">TTT&#x200b;CCC&#x200b;ATC&#x200b;AAA&#x200b;GTG&#x200b;ACC&#x200b;AG</td>
</tr>
<tr>
<td align="left">OR1L3-R</td>
<td align="left">TCC&#x200b;AAC&#x200b;CTG&#x200b;ACA&#x200b;AGA&#x200b;CTC&#x200b;TC</td>
</tr>
<tr>
<td align="left">OR9A2-F</td>
<td align="left">GAA&#x200b;ATC&#x200b;CAA&#x200b;ACA&#x200b;CCC&#x200b;ATG&#x200b;AC</td>
</tr>
<tr>
<td align="left">OR9A2-R</td>
<td align="left">CCA&#x200b;TGT&#x200b;ATT&#x200b;TCT&#x200b;TCC&#x200b;TCA&#x200b;GCC</td>
</tr>
<tr>
<td align="left">GADPH-F</td>
<td align="left">GGA&#x200b;GCG&#x200b;AGA&#x200b;TCC&#x200b;CTC&#x200b;CAA&#x200b;AAT</td>
</tr>
<tr>
<td align="left">GADPH-R</td>
<td align="left">GGC&#x200b;TGT&#x200b;TGT&#x200b;CAT&#x200b;ACT&#x200b;TCT&#x200b;CAT&#x200b;GG</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-9">
<title>2.9 Statistical analysis</title>
<p>Statistical analysis was performed through R software (version 4.2.2) and GraphPad Prism software (version 9, San Diego, CA). Continuous normally distributed variables are presented in mean &#xb1; standard deviation (SD), and experimental results are expressed as mean &#xb1; standard error (SEM). Student&#x2019;s t-test was applied to compare the stone and control group samples, with <italic>p</italic> &#x3c; 0.05 showing a statistically significant difference. Receiver Operating Characteristic Curve (ROC) was constructed and used to evaluate the diagnostic value of CCL7 for patients with KSD.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Identification of DEGs</title>
<p>In total, 2,885 and 506 DEGs were identified from CaOx vs. control samples and CaP vs. control samples, respectively (see <xref ref-type="sec" rid="s12">Supplementary Tables S1, S2</xref>). Volcano plots showed the distribution of these DEGs (<xref ref-type="fig" rid="F1">Figures 1A, B</xref>). Subsequently, the intersection of these DEGs was identified using the Venn diagram, containing 155 significantly co-up-regulated genes and 64 co-down-regulated genes (<xref ref-type="fig" rid="F1">Figure 1C</xref> and <xref ref-type="sec" rid="s12">Supplementary Table S3</xref>). Therefore, the number of co-up-regulated DEGs was more than the number of co-down-regulated DEGs. The 30 most upregulated or downregulated DEGs were visualized in a heatmap (<xref ref-type="fig" rid="F2">Figures 2A, B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Volcano plot and Venn diagram of DEGs in the mRNA expression profiling datasets. <bold>(A)</bold> CaOx and normal renal papillary tip tissue; <bold>(B)</bold> CaP and normal renal papillary tip tissue; <bold>(C)</bold> Venn diagrams.</p>
</caption>
<graphic xlink:href="fgene-14-1267545-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Heatmap of the top 30 DEGs. <bold>(A)</bold> CaOx and normal tissue; <bold>(B)</bold> CaP and normal tissue.</p>
</caption>
<graphic xlink:href="fgene-14-1267545-g002.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 GO functional and KEGG pathway enrichment analyses of DEGs</title>
<p>To investigate the functions and mechanisms of these DEGs, GO and KEGG pathway enrichment analyses of upregulated and downregulated genes were performed. According to the results of enrichment analysis, 18 GO terms of DEGs (<italic>p</italic> &#x3c; 0.05), including 6 BP, 6 CC, and 6&#xa0;MF, were displayed (<xref ref-type="fig" rid="F3">Figure 3A</xref>). The GO analysis showed that DEGs were significantly enriched in detection of chemical stimulus in sensory perception, detection of chemical stimulus in sensory perception of smell, and olfactory receptor activity (see <xref ref-type="sec" rid="s12">Supplementary Table S4</xref>). Moreover, 6 KEGG pathways were over-represented in the DEGs, and the olfactory transduction pathway was significantly enriched. The results of the KEGG enrichment analysis are shown in <xref ref-type="fig" rid="F3">Figure 3B</xref> and <xref ref-type="sec" rid="s12">Supplementary Table S5</xref>.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Pathway enrichment analysis. <bold>(A)</bold> GO enrichment analysis of the obtained 219 genes; <bold>(B)</bold> KEGG analysis of the obtained 219 genes.</p>
</caption>
<graphic xlink:href="fgene-14-1267545-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Construction of PPI network and identification of hub genes</title>
<p>To investigate the relationships among these DEGs at the protein level, the PPI of the DEGs was obtained using STRING with a confidence score&#x3e;0.4. Then, the PPI network of these DEGs was visualized using Cytoscape. <xref ref-type="fig" rid="F4">Figure 4A</xref> presented a PPI network with 13 nodes and 27 edges, including 10 upregulated genes and 3 downregulated genes. In total, 10 genes were identified as hub genes according to the cytoHubba plugin of Cytoscape. They were all upregulated genes, and CCL7 was the top hub gene. The gene symbols and the detailed nodes and edges of the PPI network are shown in <xref ref-type="fig" rid="F4">Figure 4B</xref>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>PPI network construction of DEGs. <bold>(A)</bold> The PPI network was drawn using Cytoscape, and the network nodes represent proteins. <bold>(B)</bold> The hub genes were obtained from the PPI network.</p>
</caption>
<graphic xlink:href="fgene-14-1267545-g004.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 GSEA based on CCL7 expression</title>
<p>Eighteen RP papillary tissues were divided into two subgroups based on the median expression of CCL7. The olfactory transduction, maturity-onset diabetes of the young, linoleic acid metabolism, and fat digestion and absorption were significantly enriched in the high-CCL7 subgroup (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>GSEA based on CCL7 expression levels.</p>
</caption>
<graphic xlink:href="fgene-14-1267545-g005.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Validation of identified key mRNAs in the stone group compared with the control group</title>
<p>There was no significant difference in sex (both M/F 5:4) and age (52.8 &#xb1; 10.5 vs 54.2 &#xb1; 11.4 years) between the stone group and the control group (<xref ref-type="table" rid="T1">Table 1</xref>). The results of RT-PCR showed that CCL7 level in the stone group was significantly higher than that in the control group, which was consistent with the results of bioinformatic analysis. For the olfactory transduction pathway, the expression of OR10A5, OR9A2, and OR1L3 was significantly upregulated in the stone group compared with the control group (<xref ref-type="fig" rid="F6">Figure 6</xref>), which was also consistent with bioinformatic results.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>RT-PCR results of CCL7 and olfactory transduction pathway in cells of urine. &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01.</p>
</caption>
<graphic xlink:href="fgene-14-1267545-g006.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 ROC curve for the diagnostic value of CCL7 in patients with KSD</title>
<p>The value of CCL7 in both renal papillary tip tissues (24 patients) and urine samples from our PCR results (18 patients) in diagnosing KSD was investigated by plotting a ROC curve. As shown in <xref ref-type="fig" rid="F7">Figures 7A, B</xref>, CCL7 in renal papillary tip tissues predicted the extent of KSD with AUC &#x3d; 0.935 (<italic>p</italic> &#x3c; 0.001), and CCL7 in urine samples predicted the extent of KSD with AUC &#x3d; 0.985 (<italic>p</italic> &#x3c; 0.001). They both had high sensitivity and a specificity.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>ROC curve for the diagnostic value of CCL7 in patients with KSD. <bold>(A)</bold> CCL7 in renal papillary tip tissues. <bold>(B)</bold> CCL7 in urine samples from our PCR results.</p>
</caption>
<graphic xlink:href="fgene-14-1267545-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>Most of the kidney stones are composed of calcium crystals, with CaOx as the most frequent composition, followed by CaP. Exploring the similarities and differences in molecular mechanisms responsible for the formation of various calcium crystals can improve the treatment of KSD. However, whether KSD caused by different crystals has similar molecular mechanisms remained unclear. Therefore, we analyzed the shared genes and signaling pathways responsible for the formation of two calcium crystals to explore common targets in kidney stones with different etiologies.</p>
<p>CCL7 gene plays a key biological function in both CaOx and CaP kidney stones, indicating that CCL7 may play a critical role in the development of calcium crystals. CCL7 (C-C Motif Chemokine Ligand 7) is a member of the C-C subfamily of chemokines, encoding monocyte chemotactic protein 3 (MCP3), a secreted chemokine which attracts macrophages during inflammation and metastasis. CCL7 can summon macrophages and monocytes, amplify inflammatory processes and contribute to disease progression in kidney diseases, cardiovascular diseases, and diabetes mellitus (<xref ref-type="bibr" rid="B4">Chang, 2022</xref>). Previous studies demonstrated the relationships between CCL7 and various kidney diseases, such as acute kidney injury, renal fibrosis, kidney stone, and end-stage renal disease (ESRD) (<xref ref-type="bibr" rid="B4">Chang, 2022</xref>; <xref ref-type="bibr" rid="B28">Zhou et al., 2020</xref>). Among 92 patients with kidney stone who underwent percutaneous nephrolithotomy, CCL7 expression was markedly enhanced in the papillary tips <italic>versus</italic> urine samples (<xref ref-type="bibr" rid="B24">Sun et al., 2018</xref>). In another study, treatment with oxalate upregulated CCL7 expression in human renal proximal tubular epithelial cells (<xref ref-type="bibr" rid="B27">Xia et al., 2021</xref>). Therefore, CCL7 may contribute to the development of both CaOx and CaP stones.</p>
<p>In our study, olfactory receptor activity and olfactory transduction pathway were significantly enriched in GO functional and KEGG pathway enrichment analyses. Using GSEA, we indicated that olfactory transduction was significantly enriched in the high-CCL7 subgroup. These findings indicated that the olfactory transduction pathway was significantly activated in patients with both CaOx and CaP stones. Olfactory receptors (ORs), belonging to a super-family of G-protein-coupled receptors, are chemo-sensors that sense smells in the nose (<xref ref-type="bibr" rid="B13">Massberg and Hatt, 2018</xref>). In addition to this specialized role in the olfactory epithelium, recent studies suggested that ORs are also found in non-sensory organs like kidneys (<xref ref-type="bibr" rid="B20">Rajkumar et al., 2014</xref>; <xref ref-type="bibr" rid="B22">Shepard and Pluznick, 2016</xref>). Few studies have specifically focused on their role in renal function. Pluznick et al. demonstrated that major components of the olfactory signaling pathway were present in the kidney and played important roles in regulating glomerular filtration rate (GFR) and renin release (<xref ref-type="bibr" rid="B19">Pluznick et al., 2009</xref>). Furthermore, Pluznick et al. determined that Olfr78 regulates blood pressure by interacting with byproducts of gut microbiota (<xref ref-type="bibr" rid="B18">Pluznick et al., 2013</xref>). Moreover, a recent study by Motahharynia et al. revealed that olfactory receptors contribute to the progression of kidney fibrosis (<xref ref-type="bibr" rid="B14">Motahharynia et al., 2022</xref>).</p>
<p>The above-mentioned findings demonstrated the role of these receptors in normal renal function, but no study focused on their function in the progression of KSD. We found 7 hub genes in this study, including CCL7, LTA, MMP3, IL9, CD80, MMP10, and IL31. They were all inflammatory factors. Considering the function of ORs in macrophage response and their potential role in inflammation (<xref ref-type="bibr" rid="B25">Vadevoo et al., 2021</xref>; <xref ref-type="bibr" rid="B15">Orecchioni et al., 2022</xref>), we speculated that the activated olfactory transduction pathway plays an important role in the progression of KSD. The results of RT-PCR indicated that the tendency of CCL7 and several genes of olfactory receptors (OR10A5, OR9A2, and OR1L3) were consistent with bioinformatic results.</p>
<p>In some cases drugs are necessary to reduce the risk of calcium stone formation, but no new drugs have been developed for calcium stone prevention in the past few decades. Our results suggested that olfactory receptor maybe a potential targets for calcium stones, and olfactory receptor inhibitors Phenirat<sup>&#xae;</sup>(<xref ref-type="bibr" rid="B3">Busse et al., 2014</xref>) and citral (<xref ref-type="bibr" rid="B1">Araneda et al., 2004</xref>) or silencing of olfactory receptor may provide a promising strategy to prevent and treat kidney calcium stones. However, as well as improving receptor pharmacology, work must also be done to confirm which receptors are medically viable targets.</p>
<p>However, our study has several limitations. First, there is a fundamental difference between urine and kidney. It is difficult to obtain kidney tissue of KSD patients since the progress of minimally invasive surgical technique, and kidney tissue of CaOx animal model or in cells may not really consistent with pathological alterations in clinic CaOx patients. In addition, to investigated the common pathogenic mechanism in KSD caused by CaOx and CaP, we chose patients with mixed CaOx and CaP, which can&#x2019;t be achieved in animal model or in cells. Metabolite is highly correlated with CaOx kidney stone and the urine sample is one of the most direct and convenient body fluid for test. In a previous study, Liang et al. collected urine of urolithiasis patients and investigated lncRNA-miRNA-mRNA expression, they found most of these detected RNAs had been found to be associated with the stones formation (<xref ref-type="bibr" rid="B12">Liang et al., 2019</xref>). So mRNAs observed in urine may consistent with the natural pathogenesis of CaOx/CaP stone formation in kidney. Second, although we have enlarged the samples size, the size is still small, this may limit the statistical power and generalizability of the results. Third, a animal model or cell line validation to analyze detailed signalling pathway or detailed biological process is needed in the future.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>In summary, our comprehensive bioinformatic analysis identified several molecular targets in KSD. Despite limitations, the major findings of this study are that CCL7 may play a key role in the development of both CaOx and CaP KSD, and this process relies on olfactory transduction pathway activation.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>This study was approved by the Human Ethics Committee of the Lishui Central Hospital (approved number 2023054). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>QZ: Writing&#x2013;original draft. HW: Writing&#x2013;original draft. GH: Writing&#x2013;review and editing. LJ: Funding acquisition, Validation, Writing&#x2013;review and editing.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by funds from Medical and Health Project of Zhejiang (2021427592 and 2023583325), Spearhead and goose project of Zhejiang (2022C03172), National-Zhejiang Administration of Traditional Chinese Medicine cooperation project (GZY-ZJ-KJ-23099), and Public benefit project of Lishui (2021GYX19).</p>
</sec>
<ack>
<p>We thank all study participants and project team members.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2023.1267545/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2023.1267545/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.TIF" id="SM2" mimetype="application/TIF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table2.docx" id="SM3" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table5.docx" id="SM4" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table3.docx" id="SM5" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet2.DOCX" id="SM6" mimetype="application/DOCX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table4.docx" id="SM7" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet1.XLSX" id="SM8" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araneda</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Peterlin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chesler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Firestein</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>A pharmacological profile of the aldehyde receptor repertoire in rat olfactory epithelium</article-title>. <source>J. Physiol.</source> <volume>555</volume>, <fpage>743</fpage>&#x2013;<lpage>756</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2003.058040</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arcidiacono</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mingione</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Macrina</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pivari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Soldati</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vezzoli</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Idiopathic calcium nephrolithiasis: a review of pathogenic mechanisms in the light of genetic studies</article-title>. <source>Am. J. Nephrol.</source> <volume>40</volume>, <fpage>499</fpage>&#x2013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1159/000369833</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busse</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kudella</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gr&#xfc;ning</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Gisselmann</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>St&#xe4;nder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Luger</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>A synthetic sandalwood odorant induces wound-healing processes in human keratinocytes via the olfactory receptor OR2AT4</article-title>. <source>J. Invest. Dermatol</source>. <volume>134</volume>, <fpage>2823</fpage>&#x2013;<lpage>2832</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2014.273</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>T. T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease</article-title>. <source>Cardiovasc Diabetol.</source> <volume>21</volume>, <fpage>185</fpage>. <pub-id pub-id-type="doi">10.1186/s12933-022-01626-1</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daudon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dessombz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Frochot</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Letavernier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Haymann</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Jungers</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Comprehensive morpho-constitutional analysis of urinary stones improves etiological diagnosis and therapeutic strategy of nephrolithiasis</article-title>. <source>Comptes Rendus Chim.</source> <volume>19</volume>, <fpage>1470</fpage>&#x2013;<lpage>1491</lpage>. <pub-id pub-id-type="doi">10.1016/j.crci.2016.05.008</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dessombz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Letavernier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Haymann</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Bazin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Daudon</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Calcium phosphate stone morphology can reliably predict distal renal tubular acidosis</article-title>. <source>J. Urol.</source> <volume>193</volume>, <fpage>1564</fpage>&#x2013;<lpage>1569</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2014.12.017</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evan</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Lingeman</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>F. L.</given-names>
</name>
<name>
<surname>Parks</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Bledsoe</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Randall&#x27;s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle</article-title>. <source>J. Clin. Investig.</source> <volume>111</volume>, <fpage>607</fpage>&#x2013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1172/JCI17038</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evan</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Lingeman</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Worcester</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>J. C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones</article-title>. <source>Anat. Rec. Hob.</source> <volume>297</volume>, <fpage>731</fpage>&#x2013;<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1002/ar.22881</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeong</surname>
<given-names>I. G.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bang</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>S. S.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Association between metabolic syndrome and the presence of kidney stones in a screened population</article-title>. <source>Am. J. Kidney Dis.</source> <volume>58</volume>, <fpage>383</fpage>&#x2013;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2011.03.021</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Pearle</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>W. G.</given-names>
</name>
<name>
<surname>Gambaro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Canales</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Doizi</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Kidney stones</article-title>. <source>Nat. Rev. Dis. Prim.</source> <volume>2</volume>, <fpage>16008</fpage>. <pub-id pub-id-type="doi">10.1038/nrdp.2016.8</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leaf</surname>
<given-names>D. E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Calcium kidney stones</article-title>. <source>N. Engl. J. Med.</source> <volume>363</volume>, <fpage>2470</fpage>.</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>X. F.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W. Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>F. L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>LncRNA-miRNA-mRNA expression variation profile in the urine of calcium oxalate stone patients</article-title>. <source>BMC Med. Genomics</source> <volume>12</volume>, <fpage>57</fpage>. <pub-id pub-id-type="doi">10.1186/s12920-019-0502-y</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massberg</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hatt</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Human olfactory receptors: novel cellular functions outside of the nose</article-title>. <source>Physiol. Rev.</source> <volume>98</volume>, <fpage>1739</fpage>&#x2013;<lpage>1763</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00013.2017</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Motahharynia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kiyanpour</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Moradzadeh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yaqubi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gheisari</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Olfactory receptors contribute to progression of kidney fibrosis</article-title>. <source>NPJ Syst. Biol. Appl.</source> <volume>8</volume>, <fpage>8</fpage>. <pub-id pub-id-type="doi">10.1038/s41540-022-00217-w</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orecchioni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Matsunami</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Olfactory receptors in macrophages and inflammation</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <fpage>1029244</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.1029244</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parks</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Worcester</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>F. L.</given-names>
</name>
<name>
<surname>Evan</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Lingeman</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones</article-title>. <source>Kidney Int.</source> <volume>66</volume>, <fpage>777</fpage>&#x2013;<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1111/j.1523-1755.2004.00803.x</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfaffl</surname>
<given-names>M. W.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>A new mathematical model for relative quantification in real-time RT-PCR</article-title>. <source>Nucleic Acids Res.</source> <volume>29</volume>, <fpage>e45</fpage>. <pub-id pub-id-type="doi">10.1093/nar/29.9.e45</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pluznick</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Protzko</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Gevorgyan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peterlin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sipos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>110</volume>, <fpage>4410</fpage>&#x2013;<lpage>4415</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1215927110</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pluznick</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Rodriguez-Gil</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Eisner</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Functional expression of the olfactory signaling system in the kidney</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>106</volume>, <fpage>2059</fpage>&#x2013;<lpage>2064</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0812859106</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajkumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Aisenberg</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Acres</surname>
<given-names>O. W.</given-names>
</name>
<name>
<surname>Protzko</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Pluznick</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Identification and characterization of novel renal sensory receptors</article-title>. <source>PLoS One</source> <volume>9</volume>, <fpage>e111053</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0111053</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scales</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Hanley</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Saigal</surname>
<given-names>C. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Prevalence of kidney stones in the United States</article-title>. <source>Eur. Urol.</source> <volume>62</volume>, <fpage>160</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2012.03.052</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shepard</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Pluznick</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>How does your kidney smell? Emerging roles for olfactory receptors in renal function</article-title>. <source>Pediatr. Nephrol.</source> <volume>31</volume>, <fpage>715</fpage>&#x2013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1007/s00467-015-3181-8</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorokin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>MamoulakisMiyazawa</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Rodgers</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Talati</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lotan</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Epidemiology of stone disease across the world</article-title>. <source>World J. Urol.</source> <volume>35</volume>, <fpage>1301</fpage>&#x2013;<lpage>1320</lpage>. <pub-id pub-id-type="doi">10.1007/s00345-017-2008-6</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>A. Y.</given-names>
</name>
<name>
<surname>Hinck</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Keslar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fairchild</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Monga</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Inflammatory cytokines in the papillary tips and urine of nephrolithiasis patients</article-title>. <source>J. Endourol.</source> <volume>32</volume>, <fpage>236</fpage>&#x2013;<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1089/end.2017.0699</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vadevoo</surname>
<given-names>S. M. P.</given-names>
</name>
<name>
<surname>Gunassekaran</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chae</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The macrophage odorant receptor Olfr78 mediates the lactate-induced M2 phenotype of tumor-associated macrophages</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>118</volume>, <fpage>e2102434118</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2102434118</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Worcester</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>F. L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Clinical practice. Calcium kidney stones</article-title>. <source>N. Engl. J. Med.</source> <volume>363</volume>, <fpage>954</fpage>&#x2013;<lpage>963</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMcp1001011</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Construction and analysis of immune infiltration-related ceRNA network for kidney stones</article-title>. <source>Front. Genet.</source> <volume>12</volume>, <fpage>774155</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2021.774155</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mayr</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Noor</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hylands</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Proteomic landscape of TGF-&#x3b2;1-induced fibrogenesis in renal fibroblasts</article-title>. <source>Sci. Rep.</source> <volume>10</volume>, <fpage>19054</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-75989-4</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>